CA3211535A1 - Methods and materials for treatment of neisseria gonorrhoeae infection - Google Patents

Methods and materials for treatment of neisseria gonorrhoeae infection Download PDF

Info

Publication number
CA3211535A1
CA3211535A1 CA3211535A CA3211535A CA3211535A1 CA 3211535 A1 CA3211535 A1 CA 3211535A1 CA 3211535 A CA3211535 A CA 3211535A CA 3211535 A CA3211535 A CA 3211535A CA 3211535 A1 CA3211535 A1 CA 3211535A1
Authority
CA
Canada
Prior art keywords
infection
compound
group
alkyl
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3211535A
Other languages
English (en)
French (fr)
Inventor
Padinjaremadhorn V. RAMACHANDRAN
Mohamed Seleem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of CA3211535A1 publication Critical patent/CA3211535A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA3211535A 2021-03-26 2022-03-23 Methods and materials for treatment of neisseria gonorrhoeae infection Pending CA3211535A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163166309P 2021-03-26 2021-03-26
US63/166,309 2021-03-26
PCT/US2022/021467 WO2022204231A2 (en) 2021-03-26 2022-03-23 Methods and materials for treatment of neisseria gonorrhoeae infection

Publications (1)

Publication Number Publication Date
CA3211535A1 true CA3211535A1 (en) 2022-09-29

Family

ID=83398108

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3211535A Pending CA3211535A1 (en) 2021-03-26 2022-03-23 Methods and materials for treatment of neisseria gonorrhoeae infection

Country Status (8)

Country Link
US (1) US20250339401A1 (cg-RX-API-DMAC7.html)
EP (1) EP4313040A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024511945A (cg-RX-API-DMAC7.html)
KR (1) KR20230161962A (cg-RX-API-DMAC7.html)
CN (1) CN117396201A (cg-RX-API-DMAC7.html)
AU (1) AU2022244356A1 (cg-RX-API-DMAC7.html)
CA (1) CA3211535A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022204231A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023150719A1 (en) * 2022-02-03 2023-08-10 Purdue Research Foundation Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005500289A (ja) * 2001-06-13 2005-01-06 マグナケム インターナショナル ラボラトリーズ, インコーポレイテッド ラクトン処方物および使用方法
BRPI0620157A2 (pt) * 2005-12-15 2011-12-20 Activbiotics Pharma Llc usos de rifamicinas
US20210317099A1 (en) * 2020-04-09 2021-10-14 Purdue Research Foundation Safer, potent, and fast acting antimicrobial agents

Also Published As

Publication number Publication date
WO2022204231A3 (en) 2022-12-29
KR20230161962A (ko) 2023-11-28
CN117396201A (zh) 2024-01-12
WO2022204231A2 (en) 2022-09-29
US20250339401A1 (en) 2025-11-06
EP4313040A2 (en) 2024-02-07
AU2022244356A1 (en) 2023-09-28
EP4313040A4 (en) 2025-02-12
JP2024511945A (ja) 2024-03-18

Similar Documents

Publication Publication Date Title
US8497299B2 (en) Compositions including quinonoid derivatives of cannabinoids for therapeutic use
AU2014353087B2 (en) Anti-cancer agents and preparation thereof
EP4402126A1 (en) Ahr agonists
CN104211708B (zh) 苯并噁嗪酮衍生物及其作为抗菌剂的应用
CA3023171A1 (en) Phenyl [a]indole[2,3-g]quinolizine compounds, preparation method therefor, pharmaceutical composition, and applications thereof
KR20240055751A (ko) Bcl-2 패밀리 단백질을 분해하는 화합물 및 이의 의약에서의 응용
EP4313040A2 (en) Methods and materials for treatment of neisseria gonorrhoeae infection
CA3238595A1 (en) 15-pgdh inhibitor and use thereof
WO2020228463A1 (zh) 抗白血病硒代那可丁衍生物的制备方法及其应用
EP3369740B1 (en) New cytidine derivative dimers and applications thereof
CN110305123B (zh) 一种含有金刚烷的化合物及其在治疗癌症中的用途
CN113248524A (zh) 一种双吲哚生物碱化合物及其合成方法和用途
CN116284018A (zh) 一种呋喃并[2,3-b]喹啉衍生物的制备方法及其应用
EP4121042A1 (en) Tricyclic p2-ligand containing potent hiv-protease inhibitors
CA2493090C (fr) Nouveaux derives de benzo[b]chromeno-naphthyridin-7-one et de pyrano[2'3':7,8]quino[2,3-b]quinoxalin-7-one, leur procede de preparation et les compositions pharmaceutiques qui lescontiennent
CN119661519B (zh) 一种具有光动力抗菌作用的新型咔啉季铵盐类化合物的制备方法与应用
EP1758904B1 (en) Flavopereirine derivatives for cancer therapy
JP2002535276A (ja) 4−デメチルペンクロメジンのアシル誘導体、その使用及び調製
CN113387808B (zh) Tagalsin C二萜衍生物及其制备和用途
US20250195490A1 (en) Alpha-methylene and aminomethyl lactones and lactams for treatment of clostridioides difficile infection (cdi)
CN101230015A (zh) 含酰胺取代基的取代桂皮酸衍生物及其肿瘤细胞毒性
RU2477127C1 (ru) Получение квартернизованных производных усниновой кислоты и их биологические свойства
Baker et al. Methods for the treatment of Mycobacterium infections
CN118619903A (zh) 一种不饱和内酯类化合物及其制备方法和用途
HK40062614A (en) Anti-cancer agents and preparation thereof

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250314

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250314

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250314

R15 Change to inventor requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R15-R108 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRECT INVENTOR REQUEST RECEIVED

Effective date: 20260304

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20260305

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260305

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260313

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260313

R16 Change to inventor recorded

Free format text: ST27 STATUS EVENT CODE: A-1-1-R10-R16-R110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRECT INVENTOR REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260318

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260318

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20260318

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260323

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20260323

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260324